Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by pmartino
Group name EquipePM
Item Type Journal Article
Title 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
Creator Antunes et al.
Author Ana Antunes
Author Luis Alvarez-Vallina
Author Federico Bertoglio
Author Nicolas Bouquin
Author Stéphanie Cornen
Author Francis Duffieux
Author Pierre Ferré
Author Raphaëlle Gillet
Author Christian Jorgensen
Author Mark B. Leick
Author Bernard Maillère
Author Hélène Negre
Author Mireia Pelegrin
Author Nicolas Poirier
Author Dietmar Reusch
Author Bruno Robert
Author Guy Serre
Author Alain Vicari
Author Martin Villalba
Author Christoph Volpers
Author Gavin Vuddamalay
Author Hervé Watier
Author Thierry Wurch
Author Lennart Zabeau
Author Stefan Zielonka
Author Baolin Zhang
Author Alain Beck
Author Pierre Martineau
Abstract The annual "Antibody Industrial Symposium", co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28-29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or radioelements) and also on new cell-based therapies, such as chimeric antigenic receptor (CAR)-T cells. The symposium, which brought together scientists from academia and industry, also addressed issues concerning the production of these molecules and cells, and the necessary steps to ensure a strong intellectual property protection of these new molecules and approaches. These two days of exchanges allowed a rich discussion among the various actors in the field of therapeutic antibodies.
Publication mAbs
Volume 15
Issue 1
Pages 2211692
Date 2023
Journal Abbr MAbs
Language eng
DOI 10.1080/19420862.2023.2211692
ISSN 1942-0870
Short Title 10th antibody industrial symposium
Library Catalog PubMed
Extra PMID: 37184206 PMCID: PMC10187075
Tags Antibodies, Monoclonal, Antibody engineering, Antibody industrial symposium, antibody-related molecules, biotherapeutics, cell-based therapies, congress, corresponding, France, Immunotherapy, Adoptive, Intellectual property, last, research translation into clinic, review, therapeutic antibodies
Date Added 2023/05/22 - 10:29:35
Date Modified 2024/03/01 - 09:41:55
Notes and Attachments Full Text (Attachment)
PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés